Q2 2022

Released Aug 10, 2022, after the close

10-Q filed Aug 15, 2022, 46 days after period end · 0001493152-22-022929

Q2 2022 · 10-Q

Revenue

$2.85M

+25.8% vs Q2 2021+32.0% vs Q1 2022

Net Income

-$1.14M

N/M vs Q2 2021N/M vs Q1 2022

EPS Diluted

-$0.12

N/M vs Q2 2021no prior Q1 2022 on file

Gross Profit$1,395,000+9.4%

Operating Income-$814,000N/M

Operating Cash Flowderived-$1,072,000N/M

Free Cash Flowderived-$1,175,000N/M

Margins · derived

Gross margin48.9%−7.3 pt vs Q2 2021

Operating margin-28.6%+20.7 pt vs Q2 2021

Net margin-39.9%+9.8 pt vs Q2 2021

What the release said

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	$2.85M	$2.27M	$1.58M	$2.31M
Net Income	-$1.14M	-$1.13M	-$1.66M	-$942.00K
EPS Diluted	-$0.12	-$0.12	-$0.19	-$0.14

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR